Readers who've been sitting on a decision about a compounded GLP-1 program - any program, not only Shed - are making that decision at a moment when confirming the current status with the platform directly is more important than usual
J Biol Chem 278(45):4502145026 Twarda-Clapa A, Olczak A, Bialkowska AM, Koziolkiewicz M (2022) Advanced Glycation End-Products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs
Well explained
Leone-Bay A, Paton DR, Variano B, Leipold H, Rivera T, Miura-Fraboni J, et al
If you experience side effects, report them via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
This comes directly from the clinical trial design, and four weeks is generally sufficient for most people to adapt to each new dose level before moving up